🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, single arm study looking at the rate of major clinical ...
Status
Recruiting
Location
University of Iowa Hospitals & Clinics
Start Date
2023-03-24
Trial ID
NCT05239546
Treatments Being Tested
TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 ...
Status
Active Not Recruiting
Location
University of Hawaii
Start Date
2019-12-19
Trial ID
NCT03680508
Treatments Being Tested
This phase II trial tests how well niraparib and dostarlimab work in treati...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-10-17
Trial ID
NCT05870761
Treatments Being Tested
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
This is a first-in-human study evaluating the anti-T cell immunoglobulin an...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-07-08
Trial ID
NCT02817633
Treatments Being Tested
The purpose of this study is to find out whether the study drug, TSR-042, f...
Status
Recruiting
Location
Hartford Healthcare (Data Collection)
Start Date
2019-12-11
Trial ID
NCT04165772
Treatments Being Tested
This is a multi-center, open-label, first-in-human Phase 1 study evaluating...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-03-07
Trial ID
NCT02715284
Treatments Being Tested
This study will test whether the combination of radiation and Dostarlimab i...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activites)
Start Date
2021-04-02
Trial ID
NCT04774419
Treatments Being Tested
ENGOT-OV42 / NSGO-AVATAR: This three-arm randomized trial is to demonstrate...
Status
Withdrawn
Location
NSGO
Start Date
2019-12
Trial ID
NCT03806049
Treatments Being Tested
Carcinosarcomas (CS) (malignant mixed Müllerian tumors) are highly aggressi...
Status
Recruiting
Location
ICO Paul Papin
Start Date
2020-07-15
Trial ID
NCT03651206
Treatments Being Tested